Free Trial
NYSE:EHAB

Enhabit (EHAB) Stock Price, News & Analysis

$7.89
-0.06 (-0.75%)
(As of 09/6/2024 ET)
Today's Range
$7.72
$8.06
50-Day Range
$7.46
$10.36
52-Week Range
$7.12
$12.99
Volume
639,387 shs
Average Volume
558,423 shs
Market Capitalization
$395.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.35

Enhabit MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.86 Rating Score
Upside/​Downside
18.5% Upside
$9.35 Price Target
Short Interest
Bearish
6.96% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$40,050 Bought Last Quarter
Proj. Earnings Growth
7.69%
From $0.26 to $0.28 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.82 out of 5 stars

Medical Sector

810th out of 910 stocks

Home Health Care Services Industry

7th out of 8 stocks

EHAB stock logo

About Enhabit Stock (NYSE:EHAB)

Enhabit, Inc. is a leading healthcare provider that offers Medicare-certified skilled home health and hospice services in the United States. The company operates in two segments: Home Health and Hospice, providing services to adult patients needing care, including skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. Enhabit's hospice services include in-home services to terminally ill patients and their families to address patients' physical needs, including pain control and symptom management, and emotional and spiritual support.

Enhabit operates home health agencies in approximately 34 states, with a concentration in the southern half of the United States. As of March 31, 2022, Enhabit operates in 252 home health agencies and 99 hospice agencies across 34 states. Enhabit provides practices to treat chronic diseases and conditions, including diabetes, arthritis, hypertension,  Alzheimer's disease, spinal stenosis, low vision,  Parkinson's disease, complex wound care, osteoporosis, and chronic pain, along with disease-specific plans for patients with diabetes, post-orthopedic surgery or injury, congestive heart failure,  and respiratory diseases.

Enhabit started as HealthSouth, founded in 1984 by Beam Scrushy and Richard Scrushy. In the early 2000s, the company restructured and rebranded into Encompass Health after being caught up in an accounting scandal. In Q2 of 2022, Enhabit, the healthcare and hospice division, became an independent public company, having completed its spinoff from Encompass Health Corporation. 

Barb Jacobsmeyer was named President and CEO of Enhabit Home Health & Hospice in June 2021. Jacobsmeyer came to Enhabit from Encompass Health, where she served as the company's executive vice president of operations. 

In Q3 of 2022, Enhabit, Inc. announced the acquisition of Caring Hearts Hospice, a locally-owned hospice agency in Texas. The acquisition adds four hospice locations in Texas to Enhabit's existing presence in the state. Ehnabit continues to expand, setting aside approximately one hundred million dollars to fund future mergers and acquisitions. 

Enhabit, Inc. is committed to providing high-quality care and service to patients and their families, and its success is a testament to its dedicated team of healthcare professionals. Enhabit is well-positioned to meet the growing demand for healthcare services in the United States as a leading home health and hospice service provider. With its focus on patient care and commitment to excellence, Enhabit is poised to continue to grow and succeed in the years ahead.

Enhabit's commitment to quality care has not gone unnoticed, as they have received numerous awards and recognitions for their services. In 2021, they were named a HomeCare Elite Top Agency for the 15th year. This recognition is given to the top-performing home health agencies in the United States. They have also received a 5-star rating from the Centers for Medicare & Medicaid Services (CMS) for their home health services, indicating their high quality and patient satisfaction.

Enhabit's success can be attributed to its skilled and compassionate staff and dedication to providing comprehensive and individualized patient care. Enhabit also recognizes the importance of emotional and spiritual support for their patients and their families, particularly in hospice care. Their hospice services include pain and symptom management, spiritual counseling, palliative and dietary counseling, social worker visits, and bereavement counseling services to meet terminally ill patients and their families' individual physical, spiritual, emotional, and psychosocial needs.

EHAB Stock Price History

EHAB Stock News Headlines

Enhabit, Inc. (NYSE:EHAB) Short Interest Up 14.2% in August
Perfect Crypto Buying Opportunity for 50 Cents
When cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying with both fists. They know it's only a matter of time before another bull run. Now, Crypto Insiders Are Scooping up Lesser-Known Coins and Making Serious Bank
Analysts Set Enhabit, Inc. (NYSE:EHAB) PT at $9.35
Insider Spends US$59k Buying More Shares In Enhabit
Enhabit, Inc. (EHAB) Q2 2024 Earnings Call Transcript
Perfect Crypto Buying Opportunity for 50 Cents
When cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying with both fists. They know it's only a matter of time before another bull run. Now, Crypto Insiders Are Scooping up Lesser-Known Coins and Making Serious Bank
Enhabit Announces CFO Transition
Enhabit Reports Second Quarter 2024 Financial Results
Curreen Capital Q2 2024 Investor Letter
See More Headlines
Receive EHAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enhabit and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/06/2024
Today
9/07/2024
Next Earnings (Estimated)
11/05/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Home health care services
Sub-Industry
Healthcare
Fax
N/A
Employees
10,800
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$9.35
High Stock Price Target
$12.00
Low Stock Price Target
$8.00
Potential Upside/Downside
+18.5%
Consensus Rating
Reduce
Rating Score (0-4)
1.86
Research Coverage
7 Analysts

Profitability

Net Income
$-80,500,000.00
Pretax Margin
-0.80%

Debt

Sales & Book Value

Annual Sales
$1.04 billion
Cash Flow
$2.43 per share
Book Value
$13.93 per share

Miscellaneous

Free Float
49,203,000
Market Cap
$395.73 million
Optionable
Optionable
Beta
1.82
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Ms. Barbara Ann Jacobsmeyer B.S. (Age 57)
    M.A., P.T., President, CEO & Director
    Comp: $1.26M
  • Ms. Crissy Buchanan Carlisle (Age 51)
    Executive VP & CFO
    Comp: $611.66k
  • Ms. Tanya R. Marion (Age 49)
    Chief Human Resources Officer
    Comp: $445.86k
  • Ms. Julie Diane Jolley B.S.N. (Age 51)
    R.N., Executive Vice President of Home Health
    Comp: $642.65k
  • Ms. Jeanne Kalvaitis B.S.N. (Age 66)
    R.N., Executive Vice President of Hospice Operations
    Comp: $288.38k
  • Mr. Dylan C. Black (Age 54)
    General Counsel & Secretary
  • Mr. Ronald L. Langham Jr. (Age 46)
    M.B.A., P.T., Executive Vice President of Clinical Excellence & Strategy

EHAB Stock Analysis - Frequently Asked Questions

How have EHAB shares performed this year?

Enhabit's stock was trading at $10.35 at the start of the year. Since then, EHAB shares have decreased by 23.8% and is now trading at $7.89.
View the best growth stocks for 2024 here
.

How were Enhabit's earnings last quarter?

Enhabit, Inc. (NYSE:EHAB) posted its earnings results on Tuesday, August, 6th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.05 by $0.02. The company earned $260.60 million during the quarter, compared to the consensus estimate of $265.99 million. Enhabit had a negative net margin of 0.84% and a positive trailing twelve-month return on equity of 1.61%.

Who are Enhabit's major shareholders?

Enhabit's top institutional investors include AREX Capital Management LP (4.93%), Dimensional Fund Advisors LP (3.50%), Systematic Financial Management LP (3.27%) and Paradice Investment Management LLC (3.04%). Insiders that own company stock include Barbara Ann Jacobsmeyer, Jeffrey Bolton, Ronald Leroy Langham Jr, L Edward Shaw Jr, Erin Hoeflinger, Charles M Elson, John E D D S Maupin Jr, Gregory S Rush, Leo I Higdon Jr and Tanya Renee Marion.
View institutional ownership trends
.

How do I buy shares of Enhabit?

Shares of EHAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:EHAB) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners